Skip to Main Content

Paper Details

HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Gynecol Oncol
25
2018
Author NameAffiliation
Wendell D JonesBioinformatics and Clinical Systems
Wendell D JonesBioinformatics and Clinical Systems
  • 1 - 2

Datasets

Release 1.2